382 related articles for article (PubMed ID: 26893168)
1. A Potential Contribution of Chemokine Network Dysfunction to the Depressive Disorders.
Ślusarczyk J; Trojan E; Chwastek J; Głombik K; Basta-Kaim A
Curr Neuropharmacol; 2016; 14(7):705-20. PubMed ID: 26893168
[TBL] [Abstract][Full Text] [Related]
2. The Role of Chemokines in the Pathophysiology of Major Depressive Disorder.
Milenkovic VM; Stanton EH; Nothdurfter C; Rupprecht R; Wetzel CH
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31075818
[TBL] [Abstract][Full Text] [Related]
3. Chemokines and their receptors in the central nervous system.
Bajetto A; Bonavia R; Barbero S; Florio T; Schettini G
Front Neuroendocrinol; 2001 Jul; 22(3):147-84. PubMed ID: 11456467
[TBL] [Abstract][Full Text] [Related]
4. Noradrenaline reuptake inhibitors inhibit expression of chemokines IP-10 and RANTES and cell adhesion molecules VCAM-1 and ICAM-1 in the CNS following a systemic inflammatory challenge.
O'Sullivan JB; Ryan KM; Harkin A; Connor TJ
J Neuroimmunol; 2010 Mar; 220(1-2):34-42. PubMed ID: 20061033
[TBL] [Abstract][Full Text] [Related]
5. Cellular, synaptic, and network effects of chemokines in the central nervous system and their implications to behavior.
Sowa JE; Tokarski K
Pharmacol Rep; 2021 Dec; 73(6):1595-1625. PubMed ID: 34498203
[TBL] [Abstract][Full Text] [Related]
6. [Brain-immune interactions and implications in psychiatric disorders].
Marques AH; Cizza G; Sternberg E
Braz J Psychiatry; 2007 May; 29 Suppl 1():S27-32. PubMed ID: 17546344
[TBL] [Abstract][Full Text] [Related]
7. A review of the psychoneuroimmunologic concepts on the etiology of depressive disorders.
Vidrih B; Karlović D; Pasić MB; Uremović M; Mufić AK; Matosić A
Acta Clin Croat; 2012 Sep; 51(3):403-9. PubMed ID: 23330406
[TBL] [Abstract][Full Text] [Related]
8. [Hepatitis C, interferon a and depression: main physiopathologic hypothesis].
Vignau J; Karila L; Costisella O; Canva V
Encephale; 2005; 31(3):349-57. PubMed ID: 16142050
[TBL] [Abstract][Full Text] [Related]
9. Chemokines and chemokine receptors in the brain: implication in neuroendocrine regulation.
Callewaere C; Banisadr G; Rostène W; Parsadaniantz SM
J Mol Endocrinol; 2007 Mar; 38(3):355-63. PubMed ID: 17339398
[TBL] [Abstract][Full Text] [Related]
10. A guide to chemokines and their receptors.
Hughes CE; Nibbs RJB
FEBS J; 2018 Aug; 285(16):2944-2971. PubMed ID: 29637711
[TBL] [Abstract][Full Text] [Related]
11. The progress of chemokines and chemokine receptors in autism spectrum disorders.
Ye J; Wang H; Cui L; Chu S; Chen N
Brain Res Bull; 2021 Sep; 174():268-280. PubMed ID: 34077795
[TBL] [Abstract][Full Text] [Related]
12. Cell signalling in CNS and immune system in depression and during antidepressant treatment: focus on glial and natural killer cells.
Kovaru H; Pav M; Kovaru F; Raboch J; Fiserova A
Neuro Endocrinol Lett; 2009; 30(4):421-8. PubMed ID: 20010506
[TBL] [Abstract][Full Text] [Related]
13. Maternal immune activation by poly I:C induces expression of cytokines IL-1β and IL-13, chemokine MCP-1 and colony stimulating factor VEGF in fetal mouse brain.
Arrode-Brusés G; Brusés JL
J Neuroinflammation; 2012 Apr; 9():83. PubMed ID: 22546005
[TBL] [Abstract][Full Text] [Related]
14. Targeting the CCL2-CCR2 axis in depressive disorders.
Curzytek K; Leśkiewicz M
Pharmacol Rep; 2021 Aug; 73(4):1052-1062. PubMed ID: 34031863
[TBL] [Abstract][Full Text] [Related]
15. Brain-immune interactions and disease susceptibility.
Marques-Deak A; Cizza G; Sternberg E
Mol Psychiatry; 2005 Mar; 10(3):239-50. PubMed ID: 15685252
[TBL] [Abstract][Full Text] [Related]
16. Cytokines as biomarkers in depressive disorder: current standing and prospects.
Lichtblau N; Schmidt FM; Schumann R; Kirkby KC; Himmerich H
Int Rev Psychiatry; 2013 Oct; 25(5):592-603. PubMed ID: 24151804
[TBL] [Abstract][Full Text] [Related]
17. Neuronal chemokines: versatile messengers in central nervous system cell interaction.
de Haas AH; van Weering HR; de Jong EK; Boddeke HW; Biber KP
Mol Neurobiol; 2007 Oct; 36(2):137-51. PubMed ID: 17952658
[TBL] [Abstract][Full Text] [Related]
18. Possible contribution of IGF-1 to depressive disorder.
Szczęsny E; Slusarczyk J; Głombik K; Budziszewska B; Kubera M; Lasoń W; Basta-Kaim A
Pharmacol Rep; 2013; 65(6):1622-31. PubMed ID: 24553010
[TBL] [Abstract][Full Text] [Related]
19. Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases.
Cartier L; Hartley O; Dubois-Dauphin M; Krause KH
Brain Res Brain Res Rev; 2005 Feb; 48(1):16-42. PubMed ID: 15708626
[TBL] [Abstract][Full Text] [Related]
20. Chemokines and chemokine receptors: new actors in neuroendocrine regulations.
Rostène W; Guyon A; Kular L; Godefroy D; Barbieri F; Bajetto A; Banisadr G; Callewaere C; Conductier G; Rovère C; Mélik-Parsadaniantz S; Florio T
Front Neuroendocrinol; 2011 Jan; 32(1):10-24. PubMed ID: 20624414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
